Información del producto
Información adicional
Storage Conditions
-20°C/1 year
Applications
ELISA
IF
IHC
WB
IF
IHC
WB
Concentration
1 mg/ml
Recomended Dilution
WB 1:500-2000, IF 1:50-300, IHC 1:50-300
Type Clonality
Polyclonal
Immunogen
The antiserum was produced against synthesized peptide derived from human eNOS. AA range:1145-1194
Subcellular Location
Cell membrane. Membrane, caveola. Cytoplasm, cytoskeleton. Golgi apparatus. Specifically associates with actin cytoskeleton in the G2 phase of the cell cycle
which is favored by interaction with NOSIP and results in a reduced enzymatic activity.
which is favored by interaction with NOSIP and results in a reduced enzymatic activity.
Iso type
IgG
Tissue Source
Rabbit
Reactivity
Human
Mouse
Rat
Mouse
Rat
Human Gen
4846
Observed Band
130-140kD
Other Name
Constitutive NOS
EC-NOS
Endothelial NOS
NOS3
NOSIII
NOS type III
Nitric oxide synthase
cNOS
eNOS
endothelial
EC-NOS
Endothelial NOS
NOS3
NOSIII
NOS type III
Nitric oxide synthase
cNOS
eNOS
endothelial
Background
Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in